Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297385956> ?p ?o ?g. }
- W4297385956 endingPage "1191" @default.
- W4297385956 startingPage "1180" @default.
- W4297385956 abstract "The high incidences of COVID-19 cases are believed to be associated with high transmissibility rates, which emphasizes the need for the discovery of evidence-based antiviral therapies for curing the disease. The rationale of repurposing existing classes of antiviral small molecule therapeutics against SARS-CoV-2 infection has been expected to accelerate the tedious and expensive drug development process. While Remdesivir has been recently approved to be the first treatment option for specific groups of COVID-19 patients, combinatory therapy with potential antiviral drugs may be necessary to enhance the efficacy in different populations. Hence, a comprehensive list of investigational antimicrobial drug compounds such as Favipiravir, Fidaxomicin, Galidesivir, GC376, Ribavirin, Rifabutin, and Umifenovir were computationally evaluated in this study. We performed in silico docking and molecular dynamics simulation on the selected small molecules against RNA-dependent RNA polymerase, which is one of the key target proteins of SARS-CoV-2, using AutoDock and GROMACS. Interestingly, our results revealed that the macrocyclic antibiotic, Fidaxomicin, possesses the highest binding affinity with the lowest energy value of −8.97 kcal/mol binding to the same active sites of RdRp. GC376, Rifabutin, Umifenovir and Remdesivir were identified as the next best compounds. Therefore, the above-mentioned compounds could be considered good leads for further preclinical and clinical experimentations as potentially efficient antiviral inhibitors for combination therapies against SARS-CoV-2." @default.
- W4297385956 created "2022-09-28" @default.
- W4297385956 creator A5005963579 @default.
- W4297385956 creator A5023720113 @default.
- W4297385956 creator A5024241483 @default.
- W4297385956 creator A5039599940 @default.
- W4297385956 creator A5041647988 @default.
- W4297385956 creator A5053649508 @default.
- W4297385956 creator A5059317883 @default.
- W4297385956 creator A5064904219 @default.
- W4297385956 creator A5066995737 @default.
- W4297385956 creator A5072983915 @default.
- W4297385956 creator A5073468264 @default.
- W4297385956 date "2022-11-01" @default.
- W4297385956 modified "2023-09-30" @default.
- W4297385956 title "Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach" @default.
- W4297385956 cites W1158396691 @default.
- W4297385956 cites W1583671795 @default.
- W4297385956 cites W1965280032 @default.
- W4297385956 cites W1988249073 @default.
- W4297385956 cites W2140943911 @default.
- W4297385956 cites W2163761019 @default.
- W4297385956 cites W2171291163 @default.
- W4297385956 cites W2217917186 @default.
- W4297385956 cites W2275724996 @default.
- W4297385956 cites W2399278318 @default.
- W4297385956 cites W2468919751 @default.
- W4297385956 cites W2519928122 @default.
- W4297385956 cites W2524749194 @default.
- W4297385956 cites W2584728218 @default.
- W4297385956 cites W2793022939 @default.
- W4297385956 cites W2899117060 @default.
- W4297385956 cites W2914796231 @default.
- W4297385956 cites W2984463057 @default.
- W4297385956 cites W3005212621 @default.
- W4297385956 cites W3008047170 @default.
- W4297385956 cites W3008827533 @default.
- W4297385956 cites W3010084086 @default.
- W4297385956 cites W3011072970 @default.
- W4297385956 cites W3011848620 @default.
- W4297385956 cites W3011911783 @default.
- W4297385956 cites W3011976215 @default.
- W4297385956 cites W3012045047 @default.
- W4297385956 cites W3012296792 @default.
- W4297385956 cites W3012352458 @default.
- W4297385956 cites W3012588029 @default.
- W4297385956 cites W3015429854 @default.
- W4297385956 cites W3015993909 @default.
- W4297385956 cites W3016084006 @default.
- W4297385956 cites W3016499017 @default.
- W4297385956 cites W3016968765 @default.
- W4297385956 cites W3017149343 @default.
- W4297385956 cites W3022285953 @default.
- W4297385956 cites W3022734398 @default.
- W4297385956 cites W3025511956 @default.
- W4297385956 cites W3028036282 @default.
- W4297385956 cites W3033254656 @default.
- W4297385956 cites W3044897924 @default.
- W4297385956 cites W3045075737 @default.
- W4297385956 cites W3045602082 @default.
- W4297385956 cites W3080619169 @default.
- W4297385956 cites W3081918364 @default.
- W4297385956 cites W3096967708 @default.
- W4297385956 cites W3097940531 @default.
- W4297385956 cites W3098911933 @default.
- W4297385956 cites W3105144449 @default.
- W4297385956 cites W3109511351 @default.
- W4297385956 cites W3127036220 @default.
- W4297385956 cites W3134588011 @default.
- W4297385956 cites W3134682541 @default.
- W4297385956 cites W3153583617 @default.
- W4297385956 cites W3154574610 @default.
- W4297385956 cites W3161036171 @default.
- W4297385956 cites W3163283061 @default.
- W4297385956 cites W3190325571 @default.
- W4297385956 cites W3194951380 @default.
- W4297385956 cites W3195528664 @default.
- W4297385956 cites W4200441595 @default.
- W4297385956 cites W4200551837 @default.
- W4297385956 cites W4206504659 @default.
- W4297385956 doi "https://doi.org/10.1016/j.jiph.2022.09.007" @default.
- W4297385956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36240528" @default.
- W4297385956 hasPublicationYear "2022" @default.
- W4297385956 type Work @default.
- W4297385956 citedByCount "3" @default.
- W4297385956 countsByYear W42973859562023 @default.
- W4297385956 crossrefType "journal-article" @default.
- W4297385956 hasAuthorship W4297385956A5005963579 @default.
- W4297385956 hasAuthorship W4297385956A5023720113 @default.
- W4297385956 hasAuthorship W4297385956A5024241483 @default.
- W4297385956 hasAuthorship W4297385956A5039599940 @default.
- W4297385956 hasAuthorship W4297385956A5041647988 @default.
- W4297385956 hasAuthorship W4297385956A5053649508 @default.
- W4297385956 hasAuthorship W4297385956A5059317883 @default.
- W4297385956 hasAuthorship W4297385956A5064904219 @default.
- W4297385956 hasAuthorship W4297385956A5066995737 @default.
- W4297385956 hasAuthorship W4297385956A5072983915 @default.
- W4297385956 hasAuthorship W4297385956A5073468264 @default.